Schnieders Capital Management LLC bought a new position in shares of Stryker Corporation (NYSE:SYK – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 518 shares of the medical technology company’s stock, valued at approximately $205,000.
Several other institutional investors have also recently bought and sold shares of the business. WBH Advisory Inc. acquired a new position in Stryker during the second quarter worth about $212,000. Lyell Wealth Management LP raised its stake in Stryker by 2.3% during the second quarter. Lyell Wealth Management LP now owns 38,010 shares of the medical technology company’s stock worth $15,038,000 after acquiring an additional 869 shares in the last quarter. Calamos Wealth Management LLC raised its stake in Stryker by 3.8% during the second quarter. Calamos Wealth Management LLC now owns 34,821 shares of the medical technology company’s stock worth $13,776,000 after acquiring an additional 1,269 shares in the last quarter. Cidel Asset Management Inc. raised its stake in Stryker by 12.7% during the second quarter. Cidel Asset Management Inc. now owns 1,898 shares of the medical technology company’s stock worth $751,000 after acquiring an additional 214 shares in the last quarter. Finally, Chicago Partners Investment Group LLC raised its stake in Stryker by 6.1% during the second quarter. Chicago Partners Investment Group LLC now owns 3,852 shares of the medical technology company’s stock worth $1,544,000 after acquiring an additional 220 shares in the last quarter. Institutional investors and hedge funds own 77.09% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on SYK shares. Truist Financial lowered their price objective on Stryker from $415.00 to $407.00 and set a “hold” rating for the company in a research note on Wednesday, October 15th. Redburn Partners set a $420.00 price objective on Stryker in a research note on Thursday, September 18th. Evercore ISI lowered their price objective on Stryker from $418.00 to $410.00 and set an “outperform” rating for the company in a research note on Tuesday, October 7th. Rothschild Redb raised Stryker to a “hold” rating in a research note on Thursday, September 18th. Finally, Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Stryker in a research note on Wednesday, October 8th. Fifteen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $431.76.
Insider Buying and Selling
In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the transaction, the director directly owned 3,222,108 shares in the company, valued at approximately $1,212,962,556.60. This represents a 5.84% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Viju Menon sold 500 shares of the stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $390.61, for a total value of $195,305.00. Following the transaction, the insider owned 12,511 shares in the company, valued at $4,886,921.71. The trade was a 3.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. 5.20% of the stock is currently owned by corporate insiders.
Stryker Stock Performance
NYSE:SYK opened at $381.27 on Tuesday. The company has a market capitalization of $145.76 billion, a PE ratio of 50.50, a P/E/G ratio of 2.70 and a beta of 0.94. The company has a 50 day simple moving average of $379.49 and a two-hundred day simple moving average of $379.09. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.06 and a current ratio of 1.78. Stryker Corporation has a fifty-two week low of $329.16 and a fifty-two week high of $406.19.
Stryker (NYSE:SYK – Get Free Report) last released its earnings results on Thursday, July 31st. The medical technology company reported $3.13 earnings per share for the quarter, beating analysts’ consensus estimates of $3.07 by $0.06. The business had revenue of $6.02 billion during the quarter, compared to the consensus estimate of $5.92 billion. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The company’s revenue for the quarter was up 11.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.81 EPS. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. Research analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current year.
Stryker Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be issued a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Tuesday, September 30th. Stryker’s dividend payout ratio is presently 44.50%.
Stryker Profile
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.
Read More
- Five stocks we like better than Stryker
- How to Plot Fibonacci Price Inflection Levels
- Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done Yet
- Following Congress Stock Trades
- 3 High-Yield Banks for Investors to Buy on the Dip
- What Investors Need to Know to Beat the Market
- 5 Surprising Stocks Set to Benefit From a Future Robotics Boom
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK – Free Report).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.